Where does Nano Intelligent Biomedical Engineering Corporation Co. Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nano Intelligent Biomedical Engineering Corporation Co. Ltd. ranks #17,012 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Nano Intelligent Biomedical Engineering Corporation Co. Ltd.'s patent grant rate increasing or decreasing?

Nano Intelligent Biomedical Engineering Corporation Co. Ltd.'s recent grant velocity is -69% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Nano Intelligent Biomedical Engineering Corporation Co. Ltd.'s patents?

Nano Intelligent Biomedical Engineering Corporation Co. Ltd.'s patents average 7.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nano Intelligent Biomedical Engineering Corporation Co. Ltd.

Q: How is the Nano Intelligent Biomedical Engineering Corporation Co. Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 17 granted patents across 14 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nano ranks #17,012 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 14 technology areas.

#17,012
of 49,997 US assignees by volume: 28th percentile
by Innovation Score (28.8/100): 7.0
avg claims per patent: -69%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17012 · Foreign Corporation #17,012 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #17,012/49,997
PHOTO-FINISH Minted
CPC-FOCUS C07K · 14 areas
INNOV-THIN 28.8/100
CLAIMS-SPARSE 7.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -69% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Minted LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nano’s 28.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (35%) Velocity 1.3 pts (5%) Breadth 13.2 pts (46%) Claim depth 4.2 pts (15%)

Qualcomm Incorporated · highest

85
Nano Intelligent… · this assignee

29
3D Lighting… · lowest

7

What this shows Nano's Innovation Score is 28.8/100 (28th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nano?

Each dot is one of Nano’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nano’s own 7.0 claims/patent is at or below the 11.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Nano vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nano's grants concentrate

Nano Intelligent Biomedical Engineering Corporation Co. Ltd. is a focused PatentsView assignee: 14 CPC subclasses with 82.4% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2016. By volume, Nano sits between Minted LLC and Neuracle Science Co., Ltd..

Nano's three-year grant acceleration

Nano Intelligent Biomedical Engineering Corporation Co. Ltd. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Minted

17
Motio

17
Movestrong Functi…

17
Nami MOS

17
National Associat…

17
Neograf Solutions

17
Neuboron Therapy…

17
Neuracle Science

17
Nano Intelligent… ◀

17

What this shows Nano holds 17 patents at rank #17,011, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nano

By rank, the assignees closest to #17,011 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Nano's primary technology class.

Nano's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 28th percentile higher than 28% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Nano Intelligent Biomedical Engineering Corporation Co. Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	23.5%
2016	1	5.9%
2017	3	17.6%
2018	3	17.6%
2019	2	11.8%
2020	2	11.8%
2021	1	5.9%
2022	1	5.9%

Which technologies does Nano Intelligent Biomedical Engineering Corporation Co. Ltd. patent most?

C07K - Peptides 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

B29B - Preparation OR Pretreatment OF THE Material TO BE SHAPED; Making Granules OR PREFORMS; Recovery OF Plastics OR Other Constituents OF Waste Material Containing Plastics 1

C12Y - Enzymes 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nano Intelligent Biomedical Engineering Corporation Co. Ltd.'s patent record in context - here's where to go next.

Nano Intelligent Biomedical Engineering Corporation Co. Ltd.'s lead technology class is C07K (Peptides), 82.4% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #17,012 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nano Intelligent Biomedical Engineering Corporation Co. Ltd. against Minted LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.